Radiation sensitivity enhancing composition containing aripiprazole as active ingredient
An aripiprazole and active ingredient technology, applied in the directions of organic active ingredients, medical preparations containing active ingredients, and radiosensitizing materials, can solve the problem of unclear radiosensitization effect of aripiprazole, research, and pharmacological effects. Issues such as limited research
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Detection of radiosensitive reagents in breast cancer cells
[0044] No cytotoxicity was observed in a single treatment in radiation-resistant breast cancer cells, but a radiosensitizer drug candidate in combination with radiation therapy to enhance radiation sensitivity was identified in Enzo's drug library.
[0045] MCF-7 cells (human breast cancer cell line) were adjusted to a concentration of 5000 cells / well, then seeded into 96-well plates, and pre-cultured for 24 hours. Subsequently, the medium was removed and the drugs in Enzo's drug library were treated alone or in combination with radiation at a concentration of 5 mM each. After 96 hours, the cell viability was measured with Dogen's EZ-Cytox Cell Viability Assay Kit.
[0046] Such as figure 1 As shown, aripiprazole was identified as a radiosensitizer, and although drug treatment alone had no effect on cell viability, when combined with radiation, aripiprazole reduced the viability of radioresistant cells.
Embodiment 2
[0047] Effect of Aripiprazole on the Radiation Sensitivity of Cancer Cells
[0048] In order to confirm the effect of aripiprazole on the radiosensitivity of cancer cells, a cell viability assay experiment was carried out on radioresistant breast cancer cells using MTT colorimetry as follows.
[0049] After the MCF-7 cells were adjusted to a concentration of 5000 cells / well, they were inoculated into 96-well plates and pre-cultured for 24 hours. Then, the medium was removed and aripiprazole (5 μM, 10 μM, 20 μM) was treated alone or in combination with radiation. After 96 hours, the cell viability was measured with Dogen's EZ-Cytox Cell Viability Assay Kit.
[0050] Such as figure 2 As shown, it was found that when combined with radiation, the survival rate reduction effect was superior to that of aripiprazole alone. Aripiprazole was found to have an excellent radiosensitizing effect in a concentration-dependent manner.
Embodiment 3
[0051] Effect of Aripiprazole on Radiation-Induced Apoptosis in Cancer Cells
[0052] It has recently been reported that aripiprazole can induce apoptosis in cancer cells. In order to confirm the effect of aripiprazole on radiation-induced apoptosis in cancer cells, PARP cleavage and DNA fragmentation assays were performed on cancer cells as follows .
[0053] MCF-7 cells were treated with aripiprazole (1 μM, 5 μM, 10 μM, 20 μM) alone or in combination with radiation. After 24 hr, after washing with PBS, proteins were extracted from the cells, and the extent of PARP cleavage was confirmed by western blotting.
[0054] Such as image 3 As shown, it was found that when combined with radiation, the PARP cleavage-inducing effect was superior to that of aripiprazole alone. Aripiprazole was found to induce apoptosis in irradiated cancer cells in a concentration-dependent manner.
[0055] After adjusting the concentration of MCF-7 cells or U251 cells to 5000 cells / well, they wer...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com